AML, ADULT
Clinical trials for AML, ADULT explained in plain language.
Never miss a new study
Get alerted when new AML, ADULT trials appear
Sign up with your email to follow new studies for AML, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
French study tracks promising leukemia drug available through special access
Disease control Recruiting nowThis study is observing how well the drug Ivosidenib works and how safe it is for adults with a specific genetic type of acute myeloid leukemia (AML) in France. It will look back at the medical records of about 250 patients who received the drug through a special access program, …
Matched conditions: AML, ADULT
Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug combo tested for Tough-to-Treat leukemia
Disease control Recruiting nowThis early-stage study is testing a new drug called eganelisib, both by itself and combined with an existing chemotherapy drug (cytarabine), in adults whose acute myeloid leukemia (AML) or related blood disorder has returned or not responded to prior treatments. The main goals ar…
Matched conditions: AML, ADULT
Phase: PHASE1 • Sponsor: Stelexis BioSciences • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Major trial seeks best chemo for seniors with blood cancer
Disease control Recruiting nowThis large study aims to find out which of two chemotherapy combinations works better for older adults (ages 55-75) with a serious blood cancer called acute myeloid leukemia (AML). Researchers will compare a newer drug combo (Venetoclax + Azacitidine) against a standard, more int…
Matched conditions: AML, ADULT
Phase: PHASE3 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Personalized transfusions: treating the patient, not just the number
Symptom relief Recruiting nowThis study is for adults with advanced blood cancers (MDS or AML) who are in palliative care and need regular blood transfusions. It compares two ways to decide when to give a transfusion: the usual method based on a blood count number, versus a new method based on changes in the…
Matched conditions: AML, ADULT
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Mar 27, 2026 12:40 UTC